HIGHLIGHTS
- who: Shintaro Yanazume et al. from the Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Sakuragaoka, School of Pharmacy, Queen`s University Belfast, Lisburn Road, Belfast , BL, UK have published the research: Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies, in the Journal: (JOURNAL)
- what: Anthracyclines are important for the treatment of gynecological malignancies but their effects are modest and one of the major reasons is the lack of a tumor-targeting property. In this regard human uterine sarcoma cell line with metastatic potential MEASA C9 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.